1. Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphoma
   Jeff Hosry et al, 2016, International Journal of Cancer CrossRef
2. Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients
   Fouad Abu-Taleb et al, 2014, Journal of Cancer Research CrossRef
3. Clinical effect of standardized nursing for lymphoma patients and the influencing factors of nosocomial infection
   Dong-Na Yang et al, 2023, Medicine CrossRef
4. Hepatitis C virus and lymphoma
   Semra Paydas, 2015, Critical Reviews in Oncology/Hematology CrossRef
5. Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy
   Tzu-Ting Chen et al, 2015, Leukemia Research CrossRef
6. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysis
   Minyue Zhang et al, 2021, Cancer Cell International CrossRef
7. Primary hepatic lymphoma diagnosed with diffuse large B cell lymphoma originating from a germinal center B cell
   Hideko Ohama et al, 2022, Kanzo CrossRef
8. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
   Vincenzo Occhipinti et al, 2019, Digestive and Liver Disease CrossRef
9. Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy
   Manal A. Salah-Eldin et al, 2014, Annals of Hematology CrossRef
10. Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma
    Joji Shimono et al, 2018, Oncotarget CrossRef
11. Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients
    Tamer A. Elbedewy et al, 2020, Current Cancer Drug Targets CrossRef
12. Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index
    Yi-Yang Chen et al, 2015, Cancer Epidemiology CrossRef
13. Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Ivan Dlouhy et al, 2017, Annals of Hematology CrossRef